A Phase III, Multicentre, Randomised, Double-blind, Chronicdosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease (COPD) wi

Project Details

StatusActive
Effective start/end date1/01/2531/12/26

Funding

  • AstraZeneca: A$40,000.00